Antiviral activity and safety of the hepatitis B core inhibitor ABI-H0731 administered with a nucleos(t)ide reverse transcriptase inhibitor in patients with HBeAg-negative chronic hepatitis B infection Fung, S., Sulkowski, M., Lalezari, J., Schiff, E. R., Dieterich, D., Hassanein, T., Kwo, P., Elkhashab, M., Nahass, R., Ayoub, W., Han, S., Bonacini, M., Alves, K., Zayed, H., Huang, Q., Colonno, R., Knox, S., Ramji, A., Bennett, M., Gane, E., Ravendhran, N., Park, J., Jacobson, I., Bae, H., Chan, S., Hann, H., Ma, X., Nguyen, T., Yuen, M. ELSEVIER. 2020: S51-S52

View details for Web of Science ID 000786587000087